ArticlePediatric blood & cancer2026
Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431.
Katrina Winsnes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.